Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.
Aschmann HE, Musinguzi A, Kadota JL, Namale C, Kakeeto J, Nakimuli J, Akello L, Welishe F, Nakitende A, Berger C, Dowdy DW, Cattamanchi A, Semitala FC, Kerkhoff AD. Aschmann HE, et al. Among authors: musinguzi a. J Int AIDS Soc. 2024 Dec;27(12):e26390. doi: 10.1002/jia2.26390. J Int AIDS Soc. 2024. PMID: 39587885 Free PMC article.
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.
Kadota JL, Musinguzi A, Aschmann HE, Akello L, Welishe F, Nakimuli J, Berger CA, Kiwanuka N, Phillips PPJ, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC. Kadota JL, et al. Among authors: musinguzi a. Open Forum Infect Dis. 2024 Nov 14;11(11):ofae667. doi: 10.1093/ofid/ofae667. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39582503 Free PMC article.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Musinguzi A, Kasidi JR, Kadota JL, Welishe F, Nakitende A, Akello L, Nakimuli J, Kunihira LT, Opira B, Baik Y, Patel D, Sammann A, Berger CA, Aschmann HE, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PPJ, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC, Katahoire AR. Musinguzi A, et al. PLOS Glob Public Health. 2024 Oct 24;4(10):e0003347. doi: 10.1371/journal.pgph.0003347. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39446746 Free PMC article.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Musinguzi A, Kasidi JR, Kadota JL, Welishe F, Nakitende A, Akello L, Nakimuli J, Kunihira LT, Opira B, Baik Y, Patel D, Sammann A, Berger CA, Aschmann HE, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC, Katahoire AR. Musinguzi A, et al. medRxiv [Preprint]. 2024 Aug 22:2024.08.19.24308041. doi: 10.1101/2024.08.19.24308041. medRxiv. 2024. Update in: PLOS Glob Public Health. 2024 Oct 24;4(10):e0003347. doi: 10.1371/journal.pgph.0003347 PMID: 39314926 Free PMC article. Updated. Preprint.
Draft genome sequence of Acinetobacter haemolyticus strain MUWRP1017 isolated from the pus of a female inpatient at Bwera General Hospital in Uganda.
Wokorach G, Erima B, Alafi S, Kabatesi HO, Muhindo JT, Najjuka F, Kiyengo J, Kibuuka H, Musinguzi AK, Wabwire-Mangen F, Byarugaba DK. Wokorach G, et al. Among authors: musinguzi ak. Microbiol Resour Announc. 2024 Sep 10;13(9):e0056624. doi: 10.1128/mra.00566-24. Epub 2024 Aug 20. Microbiol Resour Announc. 2024. PMID: 39162454 Free PMC article.
Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda.
Kadota JL, Musinguzi A, Aschmann HE, Akello L, Welishe F, Nakimuli J, Berger CA, Kiwanuka N, Phillips PP, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC. Kadota JL, et al. Among authors: musinguzi a. medRxiv [Preprint]. 2024 Aug 9:2024.08.08.24311632. doi: 10.1101/2024.08.08.24311632. medRxiv. 2024. Update in: Open Forum Infect Dis. 2024 Nov 14;11(11):ofae667. doi: 10.1093/ofid/ofae667 PMID: 39148841 Free PMC article. Updated. Preprint.
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Semitala FC, Kadota JL, Musinguzi A, Welishe F, Nakitende A, Akello L, Kunihira Tinka L, Nakimuli J, Ritar Kasidi J, Bishop O, Nakasendwa S, Baik Y, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A. Semitala FC, et al. Among authors: musinguzi a. PLoS Med. 2024 Feb 20;21(2):e1004356. doi: 10.1371/journal.pmed.1004356. eCollection 2024 Feb. PLoS Med. 2024. PMID: 38377166 Free PMC article. Clinical Trial.
22 results